Lupin Ltd Sustainability Reports
Lupin Limited is a multinational pharmaceutical company that develops, manufactures, and markets a broad range of generic, branded generic, and complex generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company focuses on multiple therapeutic areas including anti-tuberculosis, cardiovascular, respiratory, diabetes, central nervous system, and women's health.
Sector: Manufacturing
Country: India
Exchange: Bombay Stock Exchange
LEI: 335800HHXTESDEE2FC65
FIGI: BBG001S83YQ3
12 reports from 2013 to 2026
